Zepp Health/$ZEPP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zepp Health
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
Ticker
$ZEPP
Sector
Digital Hardware
Primary listing
NYSE
Employees
765
Headquarters
Website
Zepp Health Metrics
BasicAdvanced
$685M
-
-$4.84
1.35
-
Price and volume
Market cap
$685M
Beta
1.35
52-week high
$55.99
52-week low
$2.13
Average daily volume
550K
Financial strength
Current ratio
1.097
Quick ratio
0.528
Long term debt to equity
31.939
Total debt to equity
47.485
Interest coverage (TTM)
-8.61%
Profitability
EBITDA (TTM)
-42.27
Gross margin (TTM)
37.52%
Net profit margin (TTM)
-38.81%
Operating margin (TTM)
-22.98%
Effective tax rate (TTM)
-21.86%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-5.10%
Return on equity (TTM)
-28.32%
Valuation
Price to revenue (TTM)
3.818
Price to book
3.35
Price to tangible book (TTM)
3.75
Growth
Revenue change (TTM)
-15.72%
Earnings per share change (TTM)
194.31%
3-year revenue growth (CAGR)
-34.65%
3-year earnings per share growth (CAGR)
69.83%
Bulls say / Bears say
Zepp Health returned to year-over-year revenue growth in Q2 2025, with revenues of US$59.4 million up 46.2% from Q2 2024—the first YOY growth since 2021—surpassing the upper end of guidance on strong demand for the Amazfit Bip 6, Active 2, and T-Rex 3 models. (PR Newswire)
The company narrowed its Q2 2025 GAAP net loss to US$7.7 million and adjusted net loss to US$6.16 million, improving 28.6% and 30.2% year-over-year respectively—a sign of progress toward profitability. (PR Newswire)
Management’s Q3 2025 guidance calls for net revenues of US$72.0 million–US$76.0 million, a 70–79% year-over-year increase, highlighting strong product momentum and continued demand. (PR Newswire)
Gross margin decreased to 36.2% in Q2 2025, down from 38.5% for full year 2024, due to a higher proportion of lower-margin entry-level products such as Bip 6 and Active 2, and clearance of older mid-range models. (InvestorRoom)
Zepp Health posted an operating loss of US$6.1 million and an adjusted operating loss of US$4.9 million in Q2 2025, showing the company remains unprofitable at the operating level. (PR Newswire)
Inventories increased to US$79.9 million as of June 30, 2025, as the company stocked up for upcoming launches and to mitigate tariffs, heightening risks of capital being tied up and inventory obsolescence. (InvestorRoom)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.
Zepp Health News
AllArticlesVideos
Amazfit Ambassador Ruth Croft Claims Victory at the 2025 UTMB
Business Wire2 weeks ago
Amazfit T-Rex 3 Pro Smartwatch Launches Featuring a Rugged Titanium Design and Integrated Flashlight
Business Wire2 weeks ago
Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zepp Health stock?
Zepp Health (ZEPP) has a market cap of $685M as of September 18, 2025.
What is the P/E ratio for Zepp Health stock?
The price to earnings (P/E) ratio for Zepp Health (ZEPP) stock is 0 as of September 18, 2025.
Does Zepp Health stock pay dividends?
No, Zepp Health (ZEPP) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Zepp Health dividend payment date?
Zepp Health (ZEPP) stock does not pay dividends to its shareholders.
What is the beta indicator for Zepp Health?
Zepp Health (ZEPP) has a beta rating of 1.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.